Clinical Trials Logo

Clinical Trial Summary

- The use of sunscreen on the first day after fractional ablative skin resurfacing may reduce the risk of post-inflammatory hyperpigmentation


Clinical Trial Description

- The use of sunscreen on the first day after fractional ablative skin resurfacing may reduce the risk of post-inflammatory hyperpigmentation (PIH)

- Therefore, we conducted the study to evaluate the efficacy of the use of sunscreen on the first day after fractional ablative skin resurfacing in reducing the risk of PIH. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01756664
Study type Interventional
Source Mahidol University
Contact Rungsima Wanitphakdeedecha, MD
Email rungsima.wan@mahidol.ac.th
Status Unknown status
Phase N/A
Start date August 2012
Completion date August 2013